XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.15

+2.8%

12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom jones who wrote (3918)	9/25/1997 6:55:00 PM
From: Robert K.	of 17367

Tom. If you think its marginal, I suggest you sell. I have no problem with bearish opinions. I will say though that the fda thinks the data was strong enough in meningococcemia to give it subpart e designation which essentially skips a phase 2. Also in Trauma I really doubt the fda would allow a phase 3 unless the data supports it. Of course we are not yet in p3, but it looks like its gonna happen. It makes little sense to own xoma if you dont believe in bpi products. Just food for thought. bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next